Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/25 17:38 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | 2 | M.d | 7,475 | 43.30 | 0 | 173 | 130 | D | |||||||||||||||
8/19/25 17:29 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Herr Amy E. | MN | D | 3 | M.d | 120 | 42.43 | 0 | 3 | 800 | 3 | I | |||||||||||||||
8/19/25 17:28 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Kelderman Kim | MN | DO | CEO | 3 | M.d | 3,737 | 40.25 | 0 | 93 | 51 | D | |||||||||||||||
8/19/25 17:28 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Bohnen Shane | MN | O | SVP - GC | 1 | M.d | 0 | 0.00 | 0 | 2 | 64 | 4 | D | ||||||||||||||
8/19/25 17:28 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | McManus Matthew | MN | O | P - Diag | 1 | M.d | 0 | 0.00 | 0 | 3 | 126 | 5 | D | ||||||||||||||
8/19/25 17:27 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Geist William | MN | O | P,Protei | 1 | M.d | 0 | 0.00 | 0 | 3 | 21 | 15 | D | ||||||||||||||
8/11/25 19:06 | 8/7/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | MN | D | 1 | M.d | 110 | 21.84 | 0 | 5 | 8 | 65 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |